NMC’s first spin-off company Mimetas develops microfluidics systems that mimic human organs. The ‘organs-on-a-chip’ can predict drug effects fast, cheap and reliable.

Around 2005 the term ‘organs-on-a-chip’ sprung up. Scientists began to combine microfluidics or lab-on-a-chip technology with cell cultures. One of them is Paul Vulto, researcher at the Netherlands Metabolomics Center (NMC) and co-founder of the spin-off company Mimetas. “We developed a system consisting of one or more chambers containing cell or tissue cultures connected by channels. The cell cultures can be continuously provided with nutrients and oxygen and waste products are carried off. Our aim is to mimic organ functionality as closely as possible……

(NMC Website, oktober 2012)

RSS Syndication